BIO Digital Virtual Tours
Experience Massachusetts's thriving biotech ecosystem from anywhere in the world during BIO Digital’s new virtual tour program. View the virtual tours via the BIO Digital Event Hub and network with the Massachusetts and global ag & environment community via the text chat during each tour session.
Biotech Ecosystem Tour is designed in partnership with
Massachusetts Biotechnology Council, the Massachusetts Life Sciences Center, and MassEcon.
R&D is the core of the Massachusetts life sciences ecosystem. Yet, as the Massachusetts cluster continues to grow statewide, companies are choosing to locate state of the art biomanufacturing facilities here to be close to the leading life sciences innovators. It makes sense: proximity and networks among R&D and biomanufacturing operations will make drug discovery more efficient, and ultimately help new therapies and cures reach patients faster.
With its network of high-tech, end-to-end manufacturing and development solutions, Resilience is changing the way medicine is made – leveraging innovation to better serve scientific discovery, withstand disruptive events, and reach those in need. It’s Boston, MA facility will serve as a hub for the future of biopharma manufacturing.
Lykan Bioscience, based in Hopkinton, MA, provides a true end-to-end solution for cell-based therapies offering a 64,000 square-foot, purpose-built, clinical, and commercial manufacturing facility that has been uniquely designed to fully integrate cGMP principles and advanced software solutions. Lykan’s proprietary software platform allows for timely access to process and analytical data thus enabling real time testing and product release. An integrated logistics solution enables seamless access to innovative therapies for the patients that require them.
Massachusetts is the world’s leading life sciences ecosystem and ranks near or at the top of any metric you can find. Life sciences companies of all sectors and sizes continue to find the people, ideas, and resources they need here in Massachusetts. Two such companies are Lyndra Therapeutics and Mustang Bio.
Lyndra is a fast-growing clinical-stage biotechnology company that is pioneering the first-ever oral, ultra-long-acting, sustained release therapies with its breakthrough oral medication platform. Lyndra is on a mission to fundamentally change the way people take medicine by enabling patients to take a pill once a week or even once a month, rather than daily, which could help improve medication adherence for people around the world in a number of significant disease areas. Headquartered with its R&D facilities in Watertown, Massachusetts, the Company also has a fully operational, state of the art GMP manufacturing facility in Lexington, Massachusetts.
In Worcester, Massachusetts, which serves as the anchor of the thriving life sciences cluster in the central region of the Commonwealth, we have Mustang Bio. This clinical-stage biopharmaceutical company is focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for certain cancers and tumors, as well as rare genetic diseases. Mustang Bio is growing its manufacturing hub here in Worcester, aiding its overall mission to deliver next generation therapies to patients in need worldwide.